 SAN FRANCISCO, May 28, 2021 GLOBE NEWSWIRE -- Akero Therapeutics, Inc. Nasdaq: AKRO, a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis NASH, today announced that members of the management team will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 2:30 p.m. ET. 